Analytical Data
-
Gene name
ANXA9
- Application
-
Alternative Names
ANXA9；ANX31；Annexin A9
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
O76027
-
Expression Region
8-345aa
-
AA Sequence
MAPSLTQEILSHLGLASKTAAWGTLGTLRTFLNFSVDKDAQRLLRAITGQGVDRSAIVDVLTNRSREQRQLISRNFQERTQQDLMKSLQAALSGNLERIVMALLQPTAQFDAQELRTALKASDSAVDVAIEILATRTPPQLQECLAVYKHNFQVEAVDDITSETSGILQDLLLALAKGGRDSYSGIIDYNLAEQDVQALQRAEGPSREETWVPVFTQRNPEHLIRVFDQYQRSTGQELEEAVQNRFHGDAQVALLGLASVIKNTPLYFADKLHQALQETEPNYQVLIRILISRCETDLLSIRAEFRKKFGKSLYSSLQDAVKGDCQSALLALCRAEDM
-
Molecular Weight
53.7 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
ANXA9, or Annexin A9, is a member of the annexin family of calcium-dependent phospholipid-binding proteins, which are known to play crucial roles in various cellular processes, including membrane trafficking, apoptosis, and inflammation. Recent studies have highlighted ANXA9's potential involvement in cancer biology, particularly its role in tumor growth and metastasis. It has been observed that ANXA9 expression levels can be altered in several types of cancer, suggesting its potential as a biomarker for cancer diagnosis and prognosis. In addition, ANXA9 appears to interact with various signaling pathways, influencing processes such as cell migration and invasion. Given its pivotal role, researchers have focused on producing recombinant ANXA9 protein to study its structure-function relationship and elucidate its biological functions in detail. Recombinant protein production allows for the generation of large quantities of pure protein, facilitating biochemical assays and structural analyses, which can provide insights into the mechanisms by which ANXA9 contributes to disease pathology. Furthermore, understanding the functional properties of ANXA9 can pave the way for novel therapeutic approaches targeting this protein in cancer treatment and other diseases. The ongoing research endeavors involving recombinant ANXA9 aim to clarify its role in cellular physiology and pathology, potentially leading to new diagnostic and therapeutic strategies in oncology and beyond.
